NCT02177487View on ClinicalTrials.gov

Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

January 31, 2000

Conditions
Hypertension
Interventions
DRUG

Telmisartan/hydrochlorothiazide

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY